Immunic, Inc. (IMUX) Q1 2025 Annual Earnings
IMUX·Reported May 15, 2025·Before market open
Diluted EPS came in at $-0.25 (+0.0% YoY).
Diluted EPS
$-0.25met estimate
Consensus: $-0.25
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Immunic, Inc.'s Q1 2025 earnings report.
Immunic, Inc. (IMUX) reported Q1 2025 earnings on May 15, 2025 before market open.
Immunic, Inc. reported diluted EPS of $-0.25 for Q1 2025.
EPS beat the consensus estimate of $-0.25 by $0.00.
Compared to the same quarter a year prior, diluted EPS grew 0.0% from $-0.25.
You can read the 10-K periodic report (0001280776-25-000005) directly on SEC EDGAR. The filing index links above go to sec.gov.